Self-titration of insulin in the management of people with type 2 diabetes: A practical solution to improve management in primary care

Diabetes, Obesity and Metabolism

Volumn 15, Issue 8, 2013, Pages 690-700

  Khunti, K ^a   Davies, M J ^b   Kalra, S ^c  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^c Bharti Hospital ^*  (India)

Author keywords

Cost effectiveness; Insulin analogues; Insulin therapy; Primary care; Type 2 diabetes

Indexed keywords

GLUCOSE; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE;

COST EFFECTIVENESS ANALYSIS; DIABETIC PATIENT; DRUG DOSE TITRATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; OPEN STUDY; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SELF CARE; SELF MONITORING;

EID: 84879799095     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/dom.12053     Document Type: Review

References (81)

1. World Health Organization. World Health Organization diabetes fact sheet 312 (updated 2011 August). Available from URL: http://www.who.int/mediacentre/factsheets/fs312/en/index.html. Accessed 27 July 2012.
2. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011; 94: 311-321.
3. Zhang P, Zhang X, Brown J et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 293-301.
4. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577-1589.
5. Strange P. Treat-to-target insulin titration algorithms when initiating long or intermediate acting insulin in type 2 diabetes. J Diabetes Sci Technol 2007; 1: 540-548.
6. Barag SH. Insulin therapy for management of type 2 diabetes mellitus: strategies for initiation and long-term patient adherence. J Am Osteopath Assoc 2011; 111: S13-S19.
7. National Collaborating Centre for Chronic Conditions. Type 2 Diabetes: National Clinical guideline for Management in Primary and Secondary Care (Update). London: Royal College of Physicians (updated 2008). Available from URL: http://www.nice.org.uk/nicemedia/pdf/CG66diabetesfullguideline.pdf. Accessed 27 July 2012.
8. Wright A, Burden AC, Paisey RB, Cull CA, Holman RR. Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). Diabetes Care 2002; 25: 330-336.
9. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA 1999; 281: 2005-2012.
10. U.K. Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes 1995; 44: 1249-1258.
11. Kim W, Egan JM. The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol Rev 2008; 60: 470-512.
12. Garber AJ. Incretin effects on β-cell function, replication, and mass: the human perspective. Diabetes Care 2011; 34: S258-S263.
13. Nicolucci A, Rossi MC. Incretin-based therapies: a new potential treatment approach to overcome clinical inertia in type 2 diabetes. Acta Biomed 2008; 79: 184-191.
14. Kendall DM, Cuddihy RM, Bergenstal RM. Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use. Eur J Intern Med 2009; 20 Suppl 2: S329-S339.
15. Rodbard HW, Jellinger PS, Davidson JA et al. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endocr Pract 2009; 15: 540-559.
16. IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes. Brussels: International Diabetes Federation (updated 2005). Available from URL: http://www.idf.org/webdata/docs/IDF%20GGT2D.pdf. Accessed 27 July 2012.
17. Indian National Consensus Group. Premix insulin: initiation and continuation guidelines for management of diabetes in primary care. J Assoc Physicians India 2009; 57: S42-45.
18. National Institute for Health and Clinical Excellence. Clinical guideline 87. Type 2 diabetes: the management of type 2 diabetes (partial update; updated 2009). Available from URL: http://www.nice.org.uk/nicemedia/live/12165/44320/44320.pdf. Accessed date 27 July 2012.
19. Inzucchi SE, Bergenstal RM, Buse JB et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012; 35: 1364-1379.
20. American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care 2012; 35 Suppl 1: S11-63.
21. Inzucchi SE, Bergenstal RM, Buse JB et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012; 55: 1577-1596.
22. Brunton S, Gough S, Hicks D et al. A look into the future: improving diabetes care by 2015. Curr Med Res Opin 2011; 27 Suppl 3: 65-72.
23. Pearson J, Powers MA. Systematically initiating insulin: the staged diabetes management approach. Diabetes Educ 2006; 32: 19S-28.
24. Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care 2005; 28: 2543-2545.
25. Peyrot M, Rubin RR, Lauritzen T et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005; 28: 2673-2679.
26. Funnell MM, Anderson RM. Empowerment and self-management of diabetes. Clinical Diabetes 2004; 22: 123-127.
27. Oyer DS, Shepherd MD, Coulter FC et al. A(1c) control in a primary care setting: self-titrating an insulin analog pre-mix (INITIATEplus trial). Am J Med 2009; 122: 1043-1049.
28. Marre M. Before oral agents fail: the case for starting insulin early. Int J Obes Relat Metab Disord 2002; 26 Suppl 3: S25-30.
29. O'Connor PJ. Commentary-improving diabetes care by combating clinical inertia. Health Serv Res 2005; 40: 1854-1861.
30. Khunti K, Damci T, Meneghini L, Pan CY, Yale JF. Study of Once Daily Levemir (SOLVE): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice. Diabetes Obes Metab 2012; 14: 654-661.
31. TM): patient resource utilisation following initiation of insulin detemir. 5th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2012; Abstract). 2012: A-417.
32. Rosenfalck AM, Thorsby P, Kjems L et al. Improved postprandial glycaemic control with insulin Aspart in type 2 diabetic patients treated with insulin. Acta Diabetol 2000; 37: 41-46.
33. Anderson JH Jr, Brunelle RL, Keohane P et al. Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group. Arch Intern Med 1997; 157: 1249-1255.
34. Siebenhofer A, Plank J, Berghold A et al. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database Syst Rev 2006; CD003287.
35. Holman RR, Farmer AJ, Davies MJ et al. Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med 2009; 361: 1736-1747.
36. Roden M. Optimal insulin treatment in type 2 diabetes. N Engl J Med 2009; 361: 1801-1803.
37. Ilag LL, Kerr L, Malone JK, Tan MH. Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison. Clin Ther 2007; 29: 1254-1270.
38. Gerstein HC, Yale JF, Harris SB, Issa M, Stewart JA, Dempsey E. A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study. Diabet Med 2006; 23: 736-742.
39. Davies M, Storms F, Shutler S, Bianchi-Biscay M, Gomis R. Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine. Diabetes Care 2005; 28: 1282-1288.
40. Blonde L, Merilainen M, Karwe V, Raskin P. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study. Diabetes Obes Metab 2009; 11: 623-631.
41. Meneghini L, Koenen C, Weng W, Selam JL. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes - results of the randomized, controlled PREDICTIVE 303 study. Diabetes Obes Metab 2007; 9: 902-913.
42. International Diabetes Federation. Guideline on self-monitoring of blood glucose in noninsulin treated type 2 diabetes. International Diabetes Federation (updated 2009). Available from URL: http://www.idf.org/webdata/docs/SMBG_EN2.pdf. Accessed 27 July 2012.
43. Kennedy L, Herman WH, Strange P, Harris A. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial. Diabetes Care 2006; 29: 1-8.
44. Ligthelm RJ. Self-titration of biphasic insulin aspart 30/70 improves glycaemic control and allows easy intensification in a Dutch clinical practice. Prim Care Diabetes 2009; 3: 97-102.
45. Yki-Jarvinen H, Juurinen L, Alvarsson M et al. Initiate Insulin by Aggressive Titration and Education (INITIATE): a randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups. Diabetes Care 2007; 30: 1364-1369.
46. Raskin P, Allen E, Hollander P et al. Initiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogs. Diabetes Care 2005; 28: 260-265.
47. Malone JK, Bai S, Campaigne BN, Reviriego J, Augendre-Ferrante B. Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with type 2 diabetes. Diabet Med 2005; 22: 374-381.
48. Mensing C, Boucher J, Cypress M et al. National standards for diabetes self-management education. Diabetes Care 2007; 30 Suppl 1: S96-103.
49. National Institute for Health and Clinical Excellence. Clinical guideline 15. Type 1 diabetes: diagnosis and management of type 1 diabetes in adults. 2009 (updated 2004);. Available from URL: http://www.nice.org.uk/nicemedia/pdf/CG015adultsquickrefguide.pdf. Accessed 27 July 2012.
50. Funnell MM, Anderson RM, Arnold MS et al. Empowerment: an idea whose time has come in diabetes education. Diabetes Educ 1991; 17: 37-41.
51. Fromer L. Implementing chronic care for COPD: planned visits, care coordination, and patient empowerment for improved outcomes. Int J Chron Obstruct Pulmon Dis 2011; 6: 605-614.
52. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff (Millwood) 2001; 20: 64-78.
53. Warsi A, Wang PS, LaValley MP, Avorn J, Solomon DH. Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. Arch Intern Med 2004; 164: 1641-1649.
54. Gillett M, Dallosso HM, Dixon S et al. Delivering the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cost effectiveness analysis. BMJ 2010; 341: c4093.
55. de Weerdt I, Visser AP, An der Veen EA. Attitude behaviour theories and diabetes education programmes. Patient Educ Counsel 1989; 14: 3-19.
56. Heisler M, Bouknight RR, Hayward RA, Smith DM, Kerr EA. The relative importance of physician communication, participatory decision making, and patient understanding in diabetes self-management. J Gen Intern Med 2002; 17: 243-252.
57. Cavanaugh K, Huizinga MM, Wallston KA et al. Association of numeracy and diabetes control. Ann Intern Med 2008; 148: 737-746.
58. Rothman R, Malone R, Bryant B, Dewalt D, Pignone M. Health literacy and diabetic control. JAMA 2002; 288: 2687-2688.
59. Schillinger D, Grumbach K, Piette J et al. Association of health literacy with diabetes outcomes. JAMA 2002; 288: 475-482.
60. Rothman RL, Malone R, Bryant B et al. The spoken knowledge in low literacy in diabetes scale: a diabetes knowledge scale for vulnerable patients. Diabetes Educ 2005; 31: 215-224.
61. Williams MV, Baker DW, Parker RM, Nurss JR. Relationship of functional health literacy to patients' knowledge of their chronic disease. A study of patients with hypertension and diabetes. Arch Intern Med 1998; 158: 166-172.
62. Huizinga MM, Carlisle AJ, Cavanaugh KL et al. Literacy, numeracy, and portion-size estimation skills. Am J Prev Med 2009; 36: 324-328.
63. Karter AJ, Subramanian U, Saha C et al. Barriers to insulin initiation: the translating research into action for diabetes insulin starts project. Diabetes Care 2010; 33: 733-735.
64. Arthur SA, Geiser HR, Arriola KR, Kripalani S. Health literacy and control in the medical encounter: a mixed-methods analysis. J Natl Med Assoc 2009; 101: 677-683.
65. Al Sayah F, Majumdar SR, Williams B, Robertson S, Johnson JA. Health literacy and health outcomes in diabetes: a systematic review. J Gen Intern Med 2012 [Epub ahead of print].
66. White RO, Wolff K, Cavanaugh KL, Rothman R. Addressing health literacy and numeracy to improve diabetes education and care. Diabetes Spectr 2010; 23: 238-243.
67. Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care 2001; 24: 561-587.
68. Mensing CR, Norris SL. Group education in diabetes: effectiveness and implementation. Diabetes Spectr 2003; 16: 96-103.
69. Executive summary: standards of medical care in diabetes-2010. Diabetes Care 2010; 33 Suppl 1: S4-10.
70. Department of Health. National service framework for diabetes: standards (updated 2001 December 14). Available from URL: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4002951. Accessed 27 July 2012.
71. Davies MJ, Heller S, Skinner TC et al. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. BMJ 2008; 336: 491-495.
72. Khunti K, Gray LJ, Skinner T et al. Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care. BMJ 2012; 344: e2333.
73. Crasto W, Jarvis J, Khunti K et al. Multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: the Microalbuminuria Education and Medication Optimisation (MEMO) study. Diabetes Res Clin Pract 2011; 93: 328-336.
74. Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care 2002; 25: 1159-1171.
75. Grey M, Boland EA, Davidson M, Yu C, Tamborlane WV. Coping skills training for youths with diabetes on intensive therapy. Appl Nurs Res 1999; 12: 3-12.
76. Rubin RR, Peyrot M, Saudek CS. The effect of a diabetes education program incorporating coping skills training on emotional well-being and diabetes self-efficacy. Diabetes Educ 1993; 19: 210-214.
77. Amiel SA, Dixon T, Mann R, Jameson K. Hypoglycaemia in type 2 diabetes. Diabet Med 2008; 25: 245-254.
78. Brownson CA, Hoerger TJ, Fisher EB, Kilpatrick KE. Cost-effectiveness of diabetes self-management programs in community primary care settings. Diabetes Educ 2009; 35: 761-769.
79. Cobden DS, Niessen LW, Barr CE, Rutten FF, Redekop WK. Relationships among self-management, patient perceptions of care, and health economic outcomes for decision-making and clinical practice in type 2 diabetes. Value Health 2010; 13: 138-147.
80. Duncan I, Ahmed T, Li QE et al. Assessing the value of the diabetes educator. Diabetes Educ 2011; 37: 638-657.
81. International Diabetes Federation. Position Statement: diabetes self-management education: a right for all. International Diabetes Federation (updated January 2011). Available from URL: http://www.idf.org/education/position-statements/self-management-education. Accessed 14 November 2012.